A potential protective effect of metformin in adenoid cystic carcinoma
• Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death.
Gespeichert in:
| Autor*in: |
Lancione, Peter J. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole - 2012transfer abstract, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:107 ; year:2020 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.oraloncology.2020.104726 |
|---|
| Katalog-ID: |
ELV050942034 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV050942034 | ||
| 003 | DE-627 | ||
| 005 | 20230624170853.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.oraloncology.2020.104726 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001300.pica |
| 035 | |a (DE-627)ELV050942034 | ||
| 035 | |a (ELSEVIER)S1368-8375(20)30162-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 650 |q VZ |
| 084 | |a 85.03 |2 bkl | ||
| 084 | |a 31.80 |2 bkl | ||
| 084 | |a 54.80 |2 bkl | ||
| 084 | |a 50.03 |2 bkl | ||
| 100 | 1 | |a Lancione, Peter J. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A potential protective effect of metformin in adenoid cystic carcinoma |
| 264 | 1 | |c 2020 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. | ||
| 700 | 1 | |a Kumar, Bhavna |4 oth | |
| 700 | 1 | |a Zhao, Songzhu |4 oth | |
| 700 | 1 | |a Mroz, Edmund A. |4 oth | |
| 700 | 1 | |a Brock, Guy |4 oth | |
| 700 | 1 | |a Rocco, James W. |4 oth | |
| 700 | 1 | |a Carrau, Ricardo L. |4 oth | |
| 700 | 1 | |a Agrawal, Amit |4 oth | |
| 700 | 1 | |a Seim, Nolan |4 oth | |
| 700 | 1 | |a Kang, Stephen Y. |4 oth | |
| 700 | 1 | |a Ozer, Enver |4 oth | |
| 700 | 1 | |a Old, Matthew O. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |d 2012transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV011194073 |
| 773 | 1 | 8 | |g volume:107 |g year:2020 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.oraloncology.2020.104726 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-MAT | ||
| 936 | b | k | |a 85.03 |j Methoden und Techniken der Betriebswirtschaft |q VZ |
| 936 | b | k | |a 31.80 |j Angewandte Mathematik |q VZ |
| 936 | b | k | |a 54.80 |j Angewandte Informatik |q VZ |
| 936 | b | k | |a 50.03 |j Methoden und Techniken der Ingenieurwissenschaften |q VZ |
| 951 | |a AR | ||
| 952 | |d 107 |j 2020 |h 0 | ||
| author_variant |
p j l pj pjl |
|---|---|
| matchkey_str |
lancionepeterjkumarbhavnazhaosongzhumroz:2020----:ptnilrtciefetfefriiaeo |
| hierarchy_sort_str |
2020 |
| bklnumber |
85.03 31.80 54.80 50.03 |
| publishDate |
2020 |
| allfields |
10.1016/j.oraloncology.2020.104726 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001300.pica (DE-627)ELV050942034 (ELSEVIER)S1368-8375(20)30162-7 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lancione, Peter J. verfasserin aut A potential protective effect of metformin in adenoid cystic carcinoma 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. Kumar, Bhavna oth Zhao, Songzhu oth Mroz, Edmund A. oth Brock, Guy oth Rocco, James W. oth Carrau, Ricardo L. oth Agrawal, Amit oth Seim, Nolan oth Kang, Stephen Y. oth Ozer, Enver oth Old, Matthew O. oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.oraloncology.2020.104726 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 107 2020 0 |
| spelling |
10.1016/j.oraloncology.2020.104726 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001300.pica (DE-627)ELV050942034 (ELSEVIER)S1368-8375(20)30162-7 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lancione, Peter J. verfasserin aut A potential protective effect of metformin in adenoid cystic carcinoma 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. Kumar, Bhavna oth Zhao, Songzhu oth Mroz, Edmund A. oth Brock, Guy oth Rocco, James W. oth Carrau, Ricardo L. oth Agrawal, Amit oth Seim, Nolan oth Kang, Stephen Y. oth Ozer, Enver oth Old, Matthew O. oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.oraloncology.2020.104726 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 107 2020 0 |
| allfields_unstemmed |
10.1016/j.oraloncology.2020.104726 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001300.pica (DE-627)ELV050942034 (ELSEVIER)S1368-8375(20)30162-7 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lancione, Peter J. verfasserin aut A potential protective effect of metformin in adenoid cystic carcinoma 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. Kumar, Bhavna oth Zhao, Songzhu oth Mroz, Edmund A. oth Brock, Guy oth Rocco, James W. oth Carrau, Ricardo L. oth Agrawal, Amit oth Seim, Nolan oth Kang, Stephen Y. oth Ozer, Enver oth Old, Matthew O. oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.oraloncology.2020.104726 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 107 2020 0 |
| allfieldsGer |
10.1016/j.oraloncology.2020.104726 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001300.pica (DE-627)ELV050942034 (ELSEVIER)S1368-8375(20)30162-7 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lancione, Peter J. verfasserin aut A potential protective effect of metformin in adenoid cystic carcinoma 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. Kumar, Bhavna oth Zhao, Songzhu oth Mroz, Edmund A. oth Brock, Guy oth Rocco, James W. oth Carrau, Ricardo L. oth Agrawal, Amit oth Seim, Nolan oth Kang, Stephen Y. oth Ozer, Enver oth Old, Matthew O. oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.oraloncology.2020.104726 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 107 2020 0 |
| allfieldsSound |
10.1016/j.oraloncology.2020.104726 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001300.pica (DE-627)ELV050942034 (ELSEVIER)S1368-8375(20)30162-7 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lancione, Peter J. verfasserin aut A potential protective effect of metformin in adenoid cystic carcinoma 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. Kumar, Bhavna oth Zhao, Songzhu oth Mroz, Edmund A. oth Brock, Guy oth Rocco, James W. oth Carrau, Ricardo L. oth Agrawal, Amit oth Seim, Nolan oth Kang, Stephen Y. oth Ozer, Enver oth Old, Matthew O. oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:107 year:2020 pages:0 https://doi.org/10.1016/j.oraloncology.2020.104726 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 107 2020 0 |
| language |
English |
| source |
Enthalten in Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole Amsterdam [u.a.] volume:107 year:2020 pages:0 |
| sourceStr |
Enthalten in Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole Amsterdam [u.a.] volume:107 year:2020 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Methoden und Techniken der Betriebswirtschaft Angewandte Mathematik Angewandte Informatik Methoden und Techniken der Ingenieurwissenschaften |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| authorswithroles_txt_mv |
Lancione, Peter J. @@aut@@ Kumar, Bhavna @@oth@@ Zhao, Songzhu @@oth@@ Mroz, Edmund A. @@oth@@ Brock, Guy @@oth@@ Rocco, James W. @@oth@@ Carrau, Ricardo L. @@oth@@ Agrawal, Amit @@oth@@ Seim, Nolan @@oth@@ Kang, Stephen Y. @@oth@@ Ozer, Enver @@oth@@ Old, Matthew O. @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011194073 |
| dewey-sort |
3610 |
| id |
ELV050942034 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV050942034</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624170853.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.oraloncology.2020.104726</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001300.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV050942034</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1368-8375(20)30162-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">650</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lancione, Peter J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A potential protective effect of metformin in adenoid cystic carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Bhavna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Songzhu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mroz, Edmund A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brock, Guy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rocco, James W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carrau, Ricardo L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agrawal, Amit</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seim, Nolan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kang, Stephen Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ozer, Enver</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Old, Matthew O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011194073</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:107</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.oraloncology.2020.104726</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.03</subfield><subfield code="j">Methoden und Techniken der Betriebswirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.80</subfield><subfield code="j">Angewandte Mathematik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.80</subfield><subfield code="j">Angewandte Informatik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.03</subfield><subfield code="j">Methoden und Techniken der Ingenieurwissenschaften</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">107</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Lancione, Peter J. |
| spellingShingle |
Lancione, Peter J. ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 A potential protective effect of metformin in adenoid cystic carcinoma |
| authorStr |
Lancione, Peter J. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011194073 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 650 - Management & auxiliary services |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl A potential protective effect of metformin in adenoid cystic carcinoma |
| topic |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 |
| topic_unstemmed |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 |
| topic_browse |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b k bk s z sz e a m ea eam g b gb j w r jw jwr r l c rl rlc a a aa n s ns s y k sy syk e o eo m o o mo moo |
| hierarchy_parent_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| hierarchy_parent_id |
ELV011194073 |
| dewey-tens |
610 - Medicine & health 650 - Management & public relations |
| hierarchy_top_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011194073 |
| title |
A potential protective effect of metformin in adenoid cystic carcinoma |
| ctrlnum |
(DE-627)ELV050942034 (ELSEVIER)S1368-8375(20)30162-7 |
| title_full |
A potential protective effect of metformin in adenoid cystic carcinoma |
| author_sort |
Lancione, Peter J. |
| journal |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| journalStr |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Lancione, Peter J. |
| container_volume |
107 |
| class |
610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Lancione, Peter J. |
| doi_str_mv |
10.1016/j.oraloncology.2020.104726 |
| dewey-full |
610 650 |
| title_sort |
a potential protective effect of metformin in adenoid cystic carcinoma |
| title_auth |
A potential protective effect of metformin in adenoid cystic carcinoma |
| abstract |
• Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. |
| abstractGer |
• Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. |
| abstract_unstemmed |
• Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT |
| title_short |
A potential protective effect of metformin in adenoid cystic carcinoma |
| url |
https://doi.org/10.1016/j.oraloncology.2020.104726 |
| remote_bool |
true |
| author2 |
Kumar, Bhavna Zhao, Songzhu Mroz, Edmund A. Brock, Guy Rocco, James W. Carrau, Ricardo L. Agrawal, Amit Seim, Nolan Kang, Stephen Y. Ozer, Enver Old, Matthew O. |
| author2Str |
Kumar, Bhavna Zhao, Songzhu Mroz, Edmund A. Brock, Guy Rocco, James W. Carrau, Ricardo L. Agrawal, Amit Seim, Nolan Kang, Stephen Y. Ozer, Enver Old, Matthew O. |
| ppnlink |
ELV011194073 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.oraloncology.2020.104726 |
| up_date |
2024-07-06T18:53:06.814Z |
| _version_ |
1803856890366525440 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV050942034</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624170853.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.oraloncology.2020.104726</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001300.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV050942034</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1368-8375(20)30162-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">650</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lancione, Peter J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A potential protective effect of metformin in adenoid cystic carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Metformin protects against recurrence in adenoid cystic carcinoma. • Metformin users experience prolonged disease-free survival. • Perineural invasion and sinonasal location increase risk of recurrence. • Age, lymph node disease, and sinonasal location increase risk of death.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Bhavna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Songzhu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mroz, Edmund A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brock, Guy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rocco, James W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carrau, Ricardo L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Agrawal, Amit</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seim, Nolan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kang, Stephen Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ozer, Enver</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Old, Matthew O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011194073</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:107</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.oraloncology.2020.104726</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.03</subfield><subfield code="j">Methoden und Techniken der Betriebswirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.80</subfield><subfield code="j">Angewandte Mathematik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.80</subfield><subfield code="j">Angewandte Informatik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.03</subfield><subfield code="j">Methoden und Techniken der Ingenieurwissenschaften</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">107</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.400278 |